M&A Deal Summary |
|
---|---|
Date | 2015-11-30 |
Target | BioStructures |
Sector | Medical Products |
Buyer(s) | Bioventus |
Deal Type | Add-on Acquisition |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2011 |
Sector | Medical Products |
Employees | 995 |
Revenue | 512M USD (2023) |
Bioventus provides clinical and cost-effective therapies and diagnostics to help patients regain active lifestyles. The company's innovative products include bone stimulation devices and osteoarthritis joint fluid therapies. Bioventus was incorporated in 2011 and is based in Durham, North Carolina.
DEAL STATS | # |
---|---|
Overall | 2 of 5 |
Sector (Medical Products) | 1 of 4 |
Type (Add-on Acquisition) | 1 of 4 |
State (North Carolina) | 1 of 1 |
Country (United States) | 2 of 4 |
Year (2015) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2014-10-13 |
Advanced Biologics - OsteoAMP Product Line
United States OsteoAMP is a tissue based bone biologic product that is used by spine surgeons to promote natural bone growth and healing. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-03-30 |
Bioness
Valencia, California, United States Bioness is a provider of neuromodulation and rehabilitation medical devices through its innovative peripheral nerve stimulation (“PNS”) therapy and premium rehabilitation solutions. Bioness was founded in 2004 and is based in Valencia, California. |
Buy | $45M |